Oral therapy for rosacea
Baldwin, H.E.
Journal of Drugs in Dermatology Jdd 5(1): 16-21
2006
ISSN/ISBN: 1545-9616 PMID: 16468287 Document Number: 9512
This article will examine oral therapies utilized in the treatment of rosacea. Important topics include recognizing which types of rosacea can benefit from oral therapy and concerns regarding the emergence of bacterial resistance.
Document emailed within 1 workday
Related Documents
Allen, K.J.; Davis, C.L.; Billings, S.D.; Mousdicas, N. 2007: Recalcitrant papulopustular rosacea in an immunocompetent patient responding to combination therapy with oral ivermectin and topical permethrin Cutis 80(2): 149-151Gandola, M. 1984: Therapy of severe acne and acne rosacea with oral 13-cis-retinoic acid (Isotretinoin) Acta Vitaminologica et Enzymologica 6(4): 325-337
Nagler, A.R..; Del Rosso, J. 2019: The use of Oral Antibiotics in the Management of Rosacea Journal of Drugs in Dermatology: Jdd 18(6): 506
Conde, J.F.; Yelverton, C.B.; Balkrishnan, R.; Fleischer, A.B.; Feldman, S.R. 2007: Managing rosacea: a review of the use of metronidazole alone and in combination with oral antibiotics Journal of Drugs in Dermatology: Jdd 6(5): 495-498
Del Rosso, J.Q.; Baldwin, H.; Webster, G. 2008: American Acne & Rosacea Society rosacea medical management guidelines Journal of drugs in dermatology: JDD 7(6): 531-533
Elewski, B.E. 2009: Results of a national rosacea patient survey: common issues that concern rosacea sufferers Journal of Drugs in Dermatology: Jdd 8(2): 120-123
Schmidt, J.B.; Raff, M.; Spona, J. 1983: Do sexual steroids contribute to the pathomechanism of rosacea? A study of estrogen and androgen receptors in acne rosacea Acta Dermato-Venereologica 63(1): 64-66
Michel, J-L.; Cabibel, F. 2003: Frequency, severity and treatment of ocular rosacea during cutaneous rosacea Annales de Dermatologie et de Venereologie 130(1 Pt 1): 20-24
Fernandez-Obregon, A.; Patton, D.L. 2007: The role of Chlamydia pneumoniae in the etiology of acne rosacea: response to the use of oral azithromycin Cutis 79(2): 163-167
Meynadier, J.; Guilhou, J.J. 1983: Papulopustular rosacea (traditional acne rosacea) La Revue du Praticien 33(35): 1837-1843
Wolf, J.E. 2005: Present and future rosacea therapy Cutis 75(3 Suppl): 4-7; Discussion: 33-36
Jänner, M. 1970: Clinical findings and therapy of acne and rosacea Die Medizinische Welt 16: 745-749
Jackson, J.M.; Kircik, L.H.; Lorenz, D.J. 2013: Efficacy of extended-release 45 mg oral minocycline and extended-release 45 mg oral minocycline plus 15% azelaic acid in the treatment of acne rosacea Journal of Drugs in Dermatology: Jdd 12(3): 292-298
Svyatenko, T.; Starostina, O. 2015: New Opportunities of Ipl-Therapy in Complex Treatment of the Rosacea Vascular Forms Georgian Medical News 243: 62-66
Modi, S.; Harting, M.; Rosen, T. 2008: Azithromycin as an alternative rosacea therapy when tetracyclines prove problematic Journal of Drugs in Dermatology: Jdd 7(9): 898-899
Del Rosso, J.Q.; Bikowski, J. 2005: Topical metronidazole combination therapy in the clinical management of rosacea Journal of Drugs in Dermatology: Jdd 4(4): 473-480
Jensen, S.L.; Holmes, R. 2003: Rosacea fulminans associated with pegylated interferon alpha-2B and ribavirin therapy Journal of Drugs in Dermatology: Jdd 2(5): 554-556
Jackson, J.M.; Pelle, M. 2011: Topical rosacea therapy: the importance of vehicles for efficacy, tolerability and compliance Journal of Drugs in Dermatology: Jdd 10(6): 627-633
Draelos, Z.D.; Gunt, H.; Levy, S.B.. 2019: Natural Skin Care Products as Adjunctive to Prescription Therapy in Moderate to Severe Rosacea Journal of Drugs in Dermatology: Jdd 18(2): 141-146
John, S.C.; Malcolm, W. 2007: Oral versus non-oral hormone replacement therapy: how important is the route of administration? Ginekologia Polska 78(7): 514-520